Home › Rating Schedule › Hemic and Lymphatic Systems

Diagnostic Code 7715: Non-Hodgkin's lymphoma

Hemic and Lymphatic Systems · 38 CFR §4.117 · All codes in this system

Evaluation criteria	Rating
When there is active disease, during treatment phase, or with indolent and non-contiguous phase of low grade NHL	100%
Note: A 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures. Two years after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no recurrence, rate on residuals under the appropriate diagnostic code(s)

Evaluation criteria

Rating

When there is active disease, during treatment phase, or with indolent and non-contiguous phase of low grade NHL

100%

Note: A 100 percent evaluation shall continue beyond the cessation of any surgical therapy, radiation therapy, antineoplastic chemotherapy, or other therapeutic procedures. Two years after discontinuance of such treatment, the appropriate disability rating shall be determined by mandatory VA examination. Any reduction in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no recurrence, rate on residuals under the appropriate diagnostic code(s)

Use this rating

Open the combined ratings calculator with this percentage already entered, then add your other rated conditions:

100% in the calculator

Source: eCFR Title 38, 38 CFR §4.117, current as of 2026-11-05. Criteria text is the regulatory text, reproduced verbatim for reference; it is not legal advice.